JP2015514074A5 - - Google Patents

Download PDF

Info

Publication number
JP2015514074A5
JP2015514074A5 JP2015501926A JP2015501926A JP2015514074A5 JP 2015514074 A5 JP2015514074 A5 JP 2015514074A5 JP 2015501926 A JP2015501926 A JP 2015501926A JP 2015501926 A JP2015501926 A JP 2015501926A JP 2015514074 A5 JP2015514074 A5 JP 2015514074A5
Authority
JP
Japan
Prior art keywords
use according
gly
positively charged
botulinum toxin
wrinkles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015501926A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015514074A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/033417 external-priority patent/WO2013142755A1/en
Publication of JP2015514074A publication Critical patent/JP2015514074A/ja
Publication of JP2015514074A5 publication Critical patent/JP2015514074A5/ja
Pending legal-status Critical Current

Links

JP2015501926A 2012-03-22 2013-03-22 局所化学的神経麻痺薬を使用して皺を処置する方法 Pending JP2015514074A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261614206P 2012-03-22 2012-03-22
US61/614,206 2012-03-22
PCT/US2013/033417 WO2013142755A1 (en) 2012-03-22 2013-03-22 Method of treatment of wrinkles using topical chemodenervating agents

Publications (2)

Publication Number Publication Date
JP2015514074A JP2015514074A (ja) 2015-05-18
JP2015514074A5 true JP2015514074A5 (enExample) 2016-05-19

Family

ID=49212026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015501926A Pending JP2015514074A (ja) 2012-03-22 2013-03-22 局所化学的神経麻痺薬を使用して皺を処置する方法

Country Status (11)

Country Link
US (2) US20130251770A1 (enExample)
EP (2) EP3103472A1 (enExample)
JP (1) JP2015514074A (enExample)
KR (1) KR20140139010A (enExample)
CN (1) CN104602703A (enExample)
AU (1) AU2013234988A1 (enExample)
BR (1) BR112014023244A2 (enExample)
CA (1) CA2867511A1 (enExample)
HK (1) HK1207007A1 (enExample)
MX (1) MX2014011376A (enExample)
WO (1) WO2013142755A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006094263A2 (en) * 2005-03-03 2006-09-08 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US9486408B2 (en) * 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CA2947006A1 (en) * 2014-04-30 2015-11-05 Eric A. Forssen Formulations of biologics for intravesical instillation
RU2018119765A (ru) 2015-10-29 2019-12-02 Реванс Терапьютикс, Инк. Инъекционные препараты на основе ботулотоксина и способы их применения, обеспечивающие длительное терапевтическое и косметического действие
EP3541358A1 (en) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermal delivery of large agents
WO2020069222A1 (en) * 2018-09-26 2020-04-02 Global Health Solutions Llc Topical neurotoxin compositions
KR20200080179A (ko) 2018-12-26 2020-07-06 아미코젠주식회사 아세틸콜린 수용체 저해 펩타이드 및 이의 용도
CN118307629A (zh) 2018-12-26 2024-07-09 思亲美有限公司 乙酰胆碱受体抑制肽及其用途
WO2023008913A1 (ko) 2021-07-27 2023-02-02 주식회사 스킨메드 아세틸콜린 수용체 결합 최적화 단축 펩타이드 및 이의 용도
KR20230017747A (ko) 2021-07-27 2023-02-06 주식회사 스킨메드 아세틸콜린 수용체 결합 최적화 단축 펩타이드 및 이의 용도

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877278A (en) 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
US5632731A (en) * 1994-11-25 1997-05-27 The Kendall Company Non-adherent wound dressing
US6444209B1 (en) 1996-10-28 2002-09-03 Wisconsin Alumni Research Foundation Hybrid botulinal neurotoxins
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
CA2558408C (en) 2004-03-03 2014-11-18 Essentia Biosystems, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
SG150570A1 (en) * 2004-03-03 2009-03-30 Revance Therapeutics Inc Compositions and methods for topical diagnostic and therapeutic transport
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
JP2005306746A (ja) * 2004-04-19 2005-11-04 Jiyugaoka Clinic 顔面用シワ治療剤
CN101123967A (zh) * 2004-05-07 2008-02-13 菲特托克斯有限公司 藻毒素的经皮给药
US7838011B2 (en) 2005-02-14 2010-11-23 Pankaj Modi Stabilized protein compositions for topical administration and methods of making same
WO2006094263A2 (en) * 2005-03-03 2006-09-08 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
NZ568216A (en) 2005-11-17 2012-09-28 Revance Therapeutics Inc Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
CN101374498A (zh) 2005-12-01 2009-02-25 麻萨诸塞州洛厄尔大学 肉毒杆菌纳米乳液
AU2007340162B2 (en) * 2006-12-29 2013-08-01 Revance Therapeutics, Inc. Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from HIV-TAT
US20100050075A1 (en) 2008-08-22 2010-02-25 Lennox Manufacturing, Inc., A Corporation Of Delaware Display apparatus and method for a control unit for an environmental control system
JP6043627B2 (ja) * 2009-06-25 2016-12-14 ルバンス セラピュティックス インク.Revance Therapeutics,Inc. アルブミン非含有ボツリヌス毒素製剤
BR112012010058A2 (pt) * 2009-10-30 2016-05-31 Duoject Inc aplicador tópico para um agente paralítico e método para aplicação do agente
ES2641068T3 (es) * 2011-01-07 2017-11-07 Revance Therapeutics, Inc. Composición tópica que comprende una toxina botulínica y un colorante

Similar Documents

Publication Publication Date Title
RU2007136616A (ru) Композиция и способ для местного применения и чрескожного введения ботулинового токсина
JP2024059717A (ja) 新しいボツリヌス毒素製剤の長期持続作用
WO2011154126A3 (en) Skin antiaging treatment
EP4349361A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
JP2015514074A (ja) 局所化学的神経麻痺薬を使用して皺を処置する方法
CN103619211A (zh) 含有化妆品组合物的皮肤美容工具及涂抹方法
WO2018068947A3 (de) Proteinhydrolysate
BR112021015751A2 (pt) Vetores de terapia genética para tratamento da doença de danon
US10667597B2 (en) Anti-aging tapes
WO2010115995A3 (en) Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
MX2017010929A (es) Polimeros de acido itaconico y usos de los mismos como un agente formador de pelicula en un producto cosmetico o para el cuidado personal.
JP2021514674A5 (enExample)
KR20120058866A (ko) 세포외기질을 모사한 지방유래 줄기세포의 줄기세포성 증진용 조성물
CN107496212A (zh) 一种含有檀香油和精华成分的润肤霜剂及制备方法
CN105380808A (zh) 一种化妆品基质及其制备方法和使用方法
KR20170136696A (ko) 무수석고 리프팅 마스크 및 그 제조 방법
FR2955112B1 (fr) Nouveaux peptides anti-age modulateurs de la survivine et compositions les comprenant
CN104223736A (zh) 面部提拉器及提拉方法
CN105213294A (zh) 具有紧致肌肤功效的护肤组合物
MD1Z5 (ro) Metodă de efectuare a masajului cosmetic al feţei
GB2522924A (en) Device for resisting the formation of wrinkles
US9974733B1 (en) Tanning massage creme, extender, buffer and method of application
CN206881072U (zh) 健身爬行手垫
Basso et al. Botulinum Toxin
WO2025122874A1 (en) Recombinant silk polypeptides and compositions made thereof